BioSpace News Archive

CareCentrix, the leader in tech-enabled post-acute and home-based solutions, has been awarded a Top Workplaces 2020 honor by The Hartford Courant.

M2GEN announced today that it has entered into an agreement with Discovery Life Sciences, a global leader in biospecimen solutions, genomic, cell, and immunohistochemistry (IHC) services, to provide M2GEN’s recently launched oncology-focused bioinformatics support services.

Rakuten Medical Inc. is proud to announce that its wholly owned subsidiary Rakuten Medical Japan K.K. has received marketing approval in Japan from the Ministry of Health, Labour and Welfare for Akalux® IV Infusion 250mg (cetuximab saratolacan sodium) to treat unresectable locally advanced or recurrent head and neck cancer.

Adial Pharmaceuticals, Inc. today announced that it has submitted a formal request to the U.S. Food and Drug Administration (FDA) in support of that AD04 should be considered eligible for an FDA expedited review program.

Happiness Biotech Group Limited (the “Company” or Nasdaq: HAPP), an innovative China -based nutraceutical and dietary supplements producer, announced today that the Company has entered into certain securities purchase agreement with three non-U.S. investors, pursuant to which the Company agreed to sell 900,000 ordinary shares a

Understanding the Impact of Immune Dysregulation in COVID-19 Patients with Down Syndrome May Lead to Tailored Prevention, Diagnosis and Treatment [25-September-2020] DENVER , Sept. 25, 2020 /PRNewswire/ -- Researchers at the Linda Crnic Institute for Down Syndrome at the University of Colorado Anschutz Medical Campus (Crnic Institute) have been awarded three grants

Medscape Education has been selected as a partner in hosting The Heart Failure Society of America Virtual Annual Scientific Meeting 2020, September 30-October 6.

The American Pharmacists Association issued the following statement after the Food and Drug Administration finalized the rule for the legal importation of drugs from Canada:

GlaxoSmithKline plc (GSK) (LSE/NYSE: GSK) today announced the US Food and Drug Administration (FDA) has approved Nucala (mepolizumab) for the treatment of adult and pediatric patients aged 12 years and older with Hypereosinophilic Syndrome (HES) for ≥ six months without an identifiable non-

PTC Therapeutics, Inc. announced that on September 21, 2020 it approved non-statutory stock options to purchase an aggregate of 75,670 shares of its common stock and 12,845 restricted stock units, each representing the right to receive one share of its common stock upon vesting, to 22 new employees.